Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Open accessAbstract
The idea that conversion of glucose to ATP is an attractive target for cancer therapy has been supported in part by the observation that glucose deprivation induces apoptosis in rodent cells transduced with the proto-oncogene MYC, but not in the parental line. Here, we found that depletion of glucose killed normal human cells irrespective of induced MYC activity and by a mechanism different from apoptosis. However, depletion of glutamine, another major nutrient consumed by cancer cells, induced apoptosis depending on MYC activity. This apoptosis was preceded by depletion of the Krebs cycle intermediates, was prevented by two Krebs cycle substrates, but was unrelated to ATP synthesis or several other reported consequences of glutamine starvation. Our results suggest that the fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy, and that understanding how glutamine metabolism is linked to cell viability might provide new approaches for treatment of cancer.
AI snapshot
Written from the paper’s full text.
TL;DR
In human cells, glucose deprivation killed normal fibroblasts independently of MYC and not by apoptosis, whereas glutamine deprivation induced MYC-dependent apoptosis. The glutamine-dependent death was linked to depletion of Krebs cycle intermediates and was prevented by pyruvate or oxaloacetate, but not by ATP, glutathione, DNA damage, protein synthesis, or mTOR mechanisms.
Key findings
- Glucose depletion killed IER-MYC human fibroblasts irrespective of ERTM-MYC activity; 0.5 mM glucose (2% of normal) killed more slowly but also independently of MYC. Death was not apoptosis, as shown by absence of chromatin condensation and failure of Bcl-2 to prevent death.
- Glutamine depletion killed IER-MYC cells faster when ERTM-MYC was active; IER control cells remained viable without glutamine regardless of OHT. Death was apoptosis via the intrinsic pathway: Bcl-2 and caspase-9 dominant-negative prevented death, while crmA had no effect.
- Apoptosis after glutamine depletion was not caused by ATP deficiency, glutathione deficiency, DNA damage, protein synthesis deficiency, mTOR inhibition, or cell cycle arrest. Glutamine deprivation depleted Krebs cycle intermediates except citrate and isocitrate; pyruvate or oxaloacetate completely prevented apoptosis but did not restore proliferation, and the NADH/NAD ratio remained unchanged.
- Nutrient requirements varied by cell type: HFF-ER-MYC reacted like IER-MYC; HA1E cells underwent apoptosis after glucose depletion and reacted to glutamine depletion like IER-MYC; RPE-hTERT cells survived without glutamine irrespective of ectopic MYC and died without glucose independently of MYC by a non-apoptotic mechanism.
Methods
- Normal human fibroblasts IMR90 were retrovirally transduced with ERTM-MYC (IER-MYC) or ERTM alone (IER); HFF, HA1E, and RPE-hTERT cells were also tested. ERTM-MYC was activated with 200 nM 4-hydroxytamoxifen (OHT), with ethanol as vehicle.
- Nutrient depletion used glucose-free or glutamine-free DMEM; standard concentrations were 10 mM glucose and 2 mM glutamine. Viability and apoptosis were assessed by annexin V/PI, Hoechst 33342 nuclear morphology, Trypan Blue, and immunoblotting/immunofluorescence.
- Metabolite and viability analyses included ATP by luciferin-luciferase, reduced glutathione by flow cytometry, NADH/NAD by enzymatic cycling, lactate by LDH reaction, and capillary electrophoresis coupled to mass spectrometry (CE-MS) for metabolite profiling. Results are presented as averages of independent experiments with SDs where indicated.
Limitations
- Stated: how abnormal MYC synergizes with glutamine depletion to induce apoptosis remains to be determined; the authors cannot exclude a combination of tested mechanisms or an unknown glutamine function. Mitochondrial NADH/NAD+ and FADH/FAD+ ratios were not measured.
- Stated: the effect of nutrient depletion varied across cell types, so conclusions may be difficult to extrapolate from one or a few experimental systems.
- Evident: the study relies on ectopically expressed inducible ERTM-MYC in cultured human cell lines rather than endogenous MYC or in vivo tumor models; several supporting observations are described as unpublished or are based on two independent experiments.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 18 cited sources checked · 0 supported · 0 flagged
- Findingown data
In normal human fibroblasts (IER-MYC), glucose deprivation kills cells irrespective of ERTM-MYC activity.
“depletion of glucose killed normal human cells irrespective of induced MYC activity and by a mechanism different from apoptosis.”
- Also stated in: § Glucose deprivation kills normal human fibroblasts not by apoptosis and largely independently of the MYC activity · plain
“depletion of glucose killed IER-MYC cells irrespective of ERTM-MYC activity (Fig. 1, A and B).”
Quote in the paperSubstantial claim - Also stated in: § Glucose deprivation kills normal human fibroblasts not by apoptosis and largely independently of the MYC activity · plain
- Findingown data
Glucose deprivation kills IER-MYC cells by a process other than apoptosis.
“by a mechanism different from apoptosis.”
- Also stated in: § Glucose deprivation kills normal human fibroblasts not by apoptosis and largely independently of the MYC activity · hedged
“cells in our system died by a process other than apoptosis, as indicated by the absence of characteristic chromatin condensation (Fig. 1 C) and the failure of Bcl-2, an inhibitor of apoptosis, to prevent cell death (Fig. 1 D).”
Quote in the paperSubstantial claim - Also stated in: § Glucose deprivation kills normal human fibroblasts not by apoptosis and largely independently of the MYC activity · hedged
- Findingown data
Glutamine depletion prevented the increase in p53 concentration caused by activation of ERTM-MYC.
“glutamine depletion even prevented the increase in p53 concentration caused by activation of ERTM-MYC”
Quote in the paperSubstantial claim - Findingown data
Glutamine deprivation-induced apoptosis in IER-MYC cells proceeds through the intrinsic pathway.
“Apoptosis was induced through the intrinsic pathway because Bcl-2 and a caspase-9 dominant-negative mutant (C9DN) prevented death (Fig. 3, A and B), whereas crmA, a viral inhibitor of the extrinsic pathway (Enari et al., 1995), had no effect (Fig. 3 D).”
Quote in the paperSubstantial claim - Findingown data
The antioxidants tiron and N-acetyl-cysteine failed to rescue glutamine-depleted cells from apoptosis.
“the antioxidants that we tested, tiron and N-acetyl-cysteine, failed to rescue the depleted cells from apoptosis (unpublished data)”
Quote in the paperSubstantial claim
- Findingown data
Oxaloacetate or pyruvate prevents apoptosis in glutamine-depleted IER-MYC cells.
“oxaloacetate, which is a membrane-permeable Krebs cycle intermediate, or pyruvate, which can enter the cycle by converting into acetyl-CoA or oxaloacetate, completely prevented apoptosis in the absence of glutamine (Fig. 8, A and B).”
Quote in the paperSubstantial claim- Rests on an assumption: Oxaloacetate is a membrane-permeable Krebs cycle intermediate and pyruvate can enter the Krebs cycle by converting into acetyl-CoA or oxaloacetate.
- Findingown data
Glutathione deficiency alone is not the cause of apoptosis induced by glutamine depletion.
“BSO failed to induce apoptosis in IER-MYC cells (Fig. 6 C), suggesting that glutathione deficiency alone could not be the cause of apoptosis induced by glutamine depletion.”
Quote in the paperSubstantial claim - Findingown data
Cell cycle arrest is not the cause of cell death induced by glutamine depletion.
“IER-MYC cells ceased to proliferate irrespective of ERTM-MYC activity if either any of the essential amino acids or glutamine were absent (unpublished data). Therefore, deregulation of cell cycle arrest by itself could not explain cell death caused by glutamine depletion.”
Quote in the paperSubstantial claim - Findingown data
Protein synthesis deficiency is not the cause of apoptosis induced by glutamine depletion.
“omitting any of the essential amino acids from the tissue culture media failed to kill cells, at least over the time sufficient to kill by omitting glutamine (Fig. 4 B). Therefore, protein synthesis was not the cause of apoptosis induced by glutamine depletion.”
Quote in the paperSubstantial claim - Findingown data
The MYC moiety of ER-MYC makes cells sensitive to glutamine depletion.
“Fig. S1 C demonstrates that the MYC moiety of ER-MYC makes cells sensitive to glutamine depletion”
Quote in the paperSubstantial claim - Findingown data
The effect of glutamine depletion on cell viability was different both quantitatively and qualitatively from DON.
“The finding that the effect of glutamine depletion on cell viability was different both quantitatively and qualitatively from DON”
Quote in the paperSubstantial claim - Findingown data
Glutamine deprivation rapidly depletes glutamate, 4-aminobutyrate, 5-oxoproline, and aspartate.
“glutamine deprivation caused rapid depletion of glutamate, 4-aminobutyrate, 5-oxoproline, and aspartate, which are products of glutamine metabolism (Fig. 9 and Table S1).”
Quote in the paperSubstantial claim - Findingown data
Glutamine deprivation was much more potent than DON in inducing apoptosis.
“we found that glutamine deprivation was much more potent than DON in inducing apoptosis”
Quote in the paperSubstantial claim - Findingown data
The effect of MYC on requirements for glutamine and glucose depends on cell type.
“Modification of nutrient requirements by acute activation of ectopically expressed MYC vary with cell type”
Quote in the paperSubstantial claim - Findingown data
No increase in ROS concentration or DNA damage was detected after activation of ERTM-MYC or depletion of glutathione.
“we detected no increase in the concentration of ROS or DNA damage either after activation of ERTM-MYC or depleting glutathione”
Quote in the paperSubstantial claim - Findingown data
Glutamine deprivation was more selective for cells with ectopically activated MYC.
“and more selective for cells with ectopically activated MYC”
Quote in the paperSubstantial claim - Findingown data
In contrast to DON, glutamine depletion was not followed by an increase in p53 concentration.
“In contrast to DON, glutamine depletion was not followed by an increase in p53 concentration”
Quote in the paperSubstantial claim - Findingown data
Pyruvate or oxaloacetate does not restore proliferation of glutamine-depleted cells.
“neither pyruvate nor oxaloacetate restored cell proliferation (Fig. 8 C; and unpublished data), which suggested that the rescue was not due to replenishing depleted glutamine but rather due to specific effect of these metabolites on cell viability.”
Quote in the paperSubstantial claim - Findingown data
Glutamine deprivation induces apoptosis in IER-MYC cells that depends on ERTM-MYC activity.
“depletion of glutamine, another major nutrient consumed by cancer cells, induced apoptosis depending on MYC activity.”
- Also stated in: § Glutamine deprivation induces apoptosis selectively in cells with acutely activated ER-MYC · plain
“depletion of glutamine killed IER-MYC cells faster if ERTM-MYC was active (Fig. 2 A).”
- Also stated in: § Glutamine deprivation induces apoptosis selectively in cells with acutely activated ER-MYC · hedged
“The IER-MYC cells died by apoptosis, as indicated by the characteristic nuclear morphology of the dead cells (Fig. 2, B and C).”
Quote in the paperSubstantial claim - Also stated in: § Glutamine deprivation induces apoptosis selectively in cells with acutely activated ER-MYC · plain
- Findingown data
ATP deficiency alone does not mediate apoptosis caused by glutamine depletion.
“a much larger decrease induced by a combination of 2-deoxyglucose, an inhibitor of glycolysis, and antimycin A, an inhibitor of mitochondrial respiration, failed to kill IER-MYC cells as efficiently as did glutamine depletion (Fig. 5, A and B). Therefore, apoptosis caused by glutamine depletion could not be mediated by ATP deficiency alone.”
Quote in the paperSubstantial claim - Findingown data
No ROS accumulation was detected after glutamine depletion.
“we detected no ROS accumulation after glutamine depletion”
Quote in the paperSubstantial claim - Findingown data
Glutamine deprivation depletes all detected Krebs cycle intermediates except citrate and isocitrate.
“All of the detected Krebs cycle intermediates, with the notable exception of citrate and isocitrate (Fig. 9), were depleted as well.”
Quote in the paperSubstantial claim - Interpretationown data
Glutamine depletion and DON activated different pathways.
“which indicated that these treatments activated different pathways”
Quote in the paperSubstantial claim - Premisecitation
Glutamine can be converted via glutamate into 2-oxoglutarate, a Krebs cycle intermediate.
“glutamine can be converted via glutamate into 2-oxoglutarate, a Krebs cycle intermediate (Kovacevic, 1972; Baggetto, 1992)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Kovacevic, 1972
Not checked in the free run.
- cites Baggetto, 1992
Not checked in the free run.
- Study design and conductown data
CE-MS was reliable in detecting relative changes in metabolite concentrations in this study.
“The changes in ATP and glutathione concentrations detected by CE-MS reflected those obtained by biochemical methods (Fig. S4 and Table S1, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1), indicating that the approach was reliable in our hands in detecting relative changes in metabolite concentrations.”
Quote in the paperSubstantial claim - Interpretationcitation
The knowledge about the relative requirement of normal and transformed cells for glucose is insufficient to make a reliable judgment about whether agents mimicking glucose deprivation can be effective in cancer therapy.
“The first part of our study reiterated the previously raised concern (Zu and Guppy, 2004) that the knowledge about the relative requirement of normal and transformed cells for glucose is still insufficient to make a reliable judgment as to whether agents that mimic glucose deprivation can be effective in cancer therapy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zu and Guppy, 2004
Not checked in the free run.
- Interpretationown data
In our experimental system, glutamine metabolism links MYC activity and increase in p53 concentration.
“which implied that in our experimental system glutamine metabolism links MYC activity and increase in p53 concentration”
Quote in the paperSubstantial claim - Interpretationreasoning
The cause of apoptosis induced by glutamine depletion is likely associated with the fate of the glutamine carbon chain.
“Because pyruvate and oxaloacetate contain no nitrogen but rescue from apoptosis induced by glutamine deficiency, the cause of apoptosis is likely to be associated with the fate of the glutamine carbon chain.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The ERTM-MYC system allows studying immediate effects of MYC by minimizing artifacts associated with clonal selection.
“This system allows studying immediate effects of MYC by minimizing the artifacts associated with clonal selection of cells that because of additional genetic changes avoided apoptosis induced by ectopic expression of MYC.”
Quote in the paperSubstantial claim - Interpretationown data
Glutamine deprivation may not need p53 to kill.
“and that glutamine deprivation may not need p53 to kill”
Quote in the paperSubstantial claim - Interpretationown data
Glutamine depletion inhibits Krebs cycle progression.
“These results indicated that glutamine depletion indeed inhibited the Krebs cycle progression.”
Quote in the paperSubstantial claim - Premisecitation
Some cancer cells can survive in vitro without glucose if supplied with glutamine and nucleosides.
“Some cancer cells can even survive in vitro without glucose at all if supplied with glutamine and nucleosides (Reitzer et al., 1979; Wice et al., 1981; Linker et al., 1985).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Reitzer et al., 1979
Not checked in the free run.
- cites Wice et al., 1981
Not checked in the free run.
- cites Linker et al., 1985
Not checked in the free run.
- Interpretationreasoning
A deficiency in glutamine causes apoptosis by affecting the Krebs cycle.
“Therefore, the findings that the Krebs cycle is deficient and the substrates of the cycle rescue from glutamine depletion suggested that a deficiency in glutamine causes apoptosis by affecting the Krebs cycle.”
Quote in the paperSubstantial claim
- May combine two claims. 11
- Classified as probably not a substantial claim. 15
May combine two claims.
Findingown dataGlutamine depletion does not induce DNA damage; it does not increase p53 and does not induce H2AX phosphorylation.
“glutamine depletion not only failed to increase the p53 concentration, but even reversed the increase induced by activation of ERTM-MYC (Fig. 7).”
- Also stated in: § Glutamine depletion does not cause DNA damage · plain
“Phosphorylation of H2AX, as detected by immunofluorescence, was induced by etoposide and by activation of ERTM-MYC, but not by glutamine depletion (Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1).”
- Also stated in: § Glutamine depletion does not cause DNA damage · hedged
“Hence, depletion of glutamine was unlikely to cause apoptosis by inducing DNA damage.”
Quote in the paperSubstantial claim- Also stated in: § Glutamine depletion does not cause DNA damage · plain
May combine two claims.
Findingown dataGlutamine depletion does not change the NADH/NAD ratio and lactate is still produced.
“the NADH/NAD ratio remained unchanged (Fig. 8 D) and lactate was still produced (Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1) after glutamine depletion, even though at a lower rate, indicating that pyruvate was unlikely to rescue from glutamine depletion by being a substrate of LDH.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamTOR inhibition is not the cause of apoptosis induced by glutamine depletion; the apoptosis does not require mTOR activity.
“rapamycin caused S6 dephosphorylation but had no effect on cell viability over the time sufficient to kill cells by glutamine depletion (Fig. 4 C). Hence, glutamine depletion caused apoptosis by affecting pathways that did not require mTOR activity.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDepletion of essential amino acids caused cell cycle arrest but not apoptosis.
“in our hands depletion of essential amino acids caused cell cycle arrest but not apoptosis”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataLactate production remains largely unchanged after depletion of glutamine and is independent of ER-MYC activity.
“Fig. S3 documents that lactate production remains largely unchanged after depletion of glutamine and is independent of ER-MYC activity”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataGlutamine depletion caused cell cycle arrest irrespective of ERTM-MYC activity.
“glutamine depletion caused cell cycle arrest irrespective of the ERTM-MYC activity (unpublished data)”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationC9DN expression prevents cell disassembly but not preceding steps of apoptosis, avoiding artifacts.
“we used IER-MYC that expressed C9DN (IER-MYC–C9DN), which prevents cell disassembly but not the preceding steps of apoptosis (Fearnhead et al., 1998), thus avoiding artifacts associated with cell decomposition.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fearnhead et al., 1998
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataIdentification of metabolites was based on retention time and exact mass measurements after alignment of both axes with reference compounds, and confirmed by spiked standards.
“Identification was based on retention time and exact mass measurements after alignment of both axes with reference compounds, and confirmed by spiked standards.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMetabolism of human cells is changed by oncogenes in various ways.
“metabolism of human cells is changed by oncogenes in various ways (Ramanathan et al., 2005)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ramanathan et al., 2005
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted).
PremisecitationGlutamine depletion kills because of stress caused by deficiency in proteins, ATP, glutathione, or nucleotides.
“previous reports suggested that depletion of glutamine kills because of stress caused by deficiency in proteins, ATP, glutathione, or nucleotides (for review see Ahluwalia et al., 1990; Fuchs and Bode, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ahluwalia et al., 1990
Not checked in the free run.
- cites Fuchs and Bode, 2006
Not checked in the free run.
May combine two claims.
Study design and conductown dataThe ERTM-MYC system functioned as expected, as shown by OHT-induced nuclear translocation and increased DNA damage sensitivity.
“Adding OHT to the tissue culture medium caused translocation of ERTM-MYC to the nucleus (Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1) and increased sensitivity of the cells to DNA damage (Fig. S1 B), which confirmed that the system functioned as expected (Eilers et al., 1989; Littlewood et al., 1995).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Eilers et al., 1989
Not checked in the free run.
- cites Littlewood et al., 1995
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPyruvate can affect cell viability by being a substrate of LDH, which oxidizes NADH to NAD.
“Pyruvate might affect cell viability by being a substrate of lactate dehydrogenase (LDH), which oxidizes NADH to NAD (Zielke et al., 1980).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zielke et al., 1980
Not checked in the free run.
May combine two claims.
PremisecitationTreatments that induce glutamine deficiency or interfere with its metabolism as a substrate for nucleotide synthesis were highly successful in animals, but turned out to be unacceptably toxic in people and were largely abandoned.
“Treatments that induce glutamine deficiency or interfere with its metabolism as a substrate for nucleotide synthesis were highly successful in animals, but turned out to be unacceptably toxic in people and were largely abandoned (Ahluwalia et al., 1990).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ahluwalia et al., 1990
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningOur study is consistent with the view that metabolic changes associated with carcinogenesis, and energy metabolism in particular, might be much more complex than Warburg postulated.
“Overall, our study is consistent with the view that metabolic changes associated with carcinogenesis, and the energy metabolism in particular, might be much more complex than Warburg postulated”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIn this system, glutamine is either the main source of Krebs cycle intermediates or regulates Krebs cycle activity.
“our observations indicated that glutamine in our system is either the main source of Krebs cycle intermediates, as in some proliferating normal and cancer cells (Reitzer et al., 1979; Moreadith and Lehninger, 1984; Zielke et al., 1984; Kovacevic et al., 1991; Baggetto, 1992; Petch and Butler, 1994), or regulates the Krebs cycle activity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe potential of glutamine metabolism as a target for cancer therapy may need revisiting.
“suggests that the potential of glutamine metabolism as a target for cancer therapy may need revisiting”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe NADH/NAD ratio determines rates of many processes, from glycolysis to histone modifications.
“the NADH/NAD ratio determines rates of many processes, from glycolysis to histone modifications (for review see Ladurner, 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ladurner, 2006
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationCE-MS estimates concentration of multiple metabolites in one sample.
“capillary electrophoresis coupled to mass spectrometry (CE-MS), an approach that estimates concentration of multiple metabolites in one sample (Soga et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Soga et al., 2003
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll changes in brightness or contrast, if any done, were applied to the entire image.
“All changes in brightness or contrast, if any done, were applied to the entire image.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningRetroviral transduction was used to decrease chances of clonal selection.
“To further decrease the chances of clonal selection, we used retroviral transduction rather than transient transfection to generate populations of normal human fibroblasts IMR90 that expressed ERTM-MYC (IER-MYC) or ERTM (IER); the latter served to exclude effects of OHT unrelated to MYC activity.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDependence of cells on glucose and the effects of its depletion vary among cell types and can depend on the combination of oncogenes expressed.
“our results demonstrated that dependence of cells on glucose and the effects of its depletion vary among cell types and can depend on the combination of oncogenes expressed in these cells.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe Krebs cycle is a hub of numerous metabolic pathways.
“the Krebs cycle is not only a source of NADH for oxidative phosphorylation, but also a “hub” of numerous metabolic pathways (http://www.tcd.ie/Biochemistry/IUBMB-Nicholson/minimaps.html)”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThe fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy.
“Our results suggest that the fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationDepletion of glucose induces apoptosis in rodent cells transduced with MYC but not in the parental cell line.
“depletion of glucose induced apoptosis in rodent cells that were transduced with MYC, an oncogene that is abnormally expressed in many human cancers (Nesbit et al., 1999), but not in the parental cell line (Shim et al., 1998).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Shim et al., 1998
Not checked in the free run.
- cites Nesbit et al., 1999
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataER-MYC is activated as expected.
“Fig. S1, A and B document that ER-MYC is activated as expected”
Quote in the paperSubstantial claim
The paper relies on this without support.
Metabolism can vary among species.
“Considering that metabolism can vary among species, and that human rather than animal tumors are of primary interest, we used human cells.”
The paper relies on this without support.
Glutamine is made by cells, making the requirement for exogenous glutamine appear unnecessary.
“However, glutamine is made by cells, which makes the requirement for exogenous glutamine appear unnecessary.”
The paper relies on this without support.
Oxaloacetate is a membrane-permeable Krebs cycle intermediate and pyruvate can enter the Krebs cycle by converting into acetyl-CoA or oxaloacetate.
“oxaloacetate, which is a membrane-permeable Krebs cycle intermediate, or pyruvate, which can enter the cycle by converting into acetyl-CoA or oxaloacetate, completely prevented apoptosis in the absence of glutamine (Fig. 8, A and B).”
The paper relies on this without support.
Why glutamine is required for cell viability is not entirely clear.
“Surprisingly, why glutamine is required for cell viability, or, in other words, why depletion of glutamine would kill cells, is not entirely clear.”
The paper relies on this without support.
p53 is mutated in many cancers.
“which is an advantage as this protein is mutated in many cancers”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Depending on tissue of origin, cancer cells use various routes of glutamine metabolism; some require exogenous glutamine for malignant proliferation, whereas others do not and can synthesize it de novo.
“Furthermore, depending on the tissue of origin, cancer cells use various routes of glutamine metabolism. Some have been shown to require an exogenous glutamine supply for malignant proliferation [71,72], whereas others do not [73] and can synthesize it de novo [74].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [71]
The Introduction states that some cancer cell lines require glutamine or its metabolites for survival, supporting a glutamine dependency. It does not establish that they require an exogenous glutamine supply specifically for malignant proliferation; the paper chiefly examines cell survival and apoptosis after glutamine depletion. The sentence’s claims about other cells synthesizing glutamine de novo have separate citations and are not judged here. (LLM, conf=0.82)
Experimental — accuracy not yet measuredCancer cells often consume glutamine, and those dependent on Myc signaling are highly sensitive to glutamine withdrawal.
“Cancer cells often consume glutamine, and those dependent on Myc signaling are highly sensitive to glutamine withdrawal (Yuneva et al., 2007).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Yuneva et al., 2007
The Introduction identifies glutamine as a major nutrient consumed by cancer cells. The Results report that glutamine deprivation induced MYC-dependent apoptosis in tested human cells, but also describe a cell type that survived despite ectopic MYC expression. The Discussion presents sensitivity of cancers with abnormally high MYC activity as a possibility to explore, rather than an established general finding. (LLM, conf=0.83)
Experimental — accuracy not yet measuredCHK1 inhibitors and glutaminase inhibitors are considered potential candidates for treating Myc-overexpressing cancers.
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [628]
Providing alpha-ketoglutarate, oxaloacetate, or pyruvate rescues cancer cell proliferation under glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates (anaplerosis).
“Providing cells with αKG, oxaloacetate, or pyruvate is sufficient to rescue cancer cell proliferation in conditions of glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates, a process termed anaplerosis (Altman et al., 2016; Weinberg et al., 2010; Yuneva et al., 2007).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2007
In certain contexts, MYC-transformed cancers become glutamine dependent and undergo apoptosis in the absence of glutamine.
“In certain contexts, MYC-transformed cancers become glutamine dependent and undergo apoptosis in the absence of glutamine (Yuneva et al., 2007).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2007
In c-myc-transformed cells, glutamine deprivation leads to TCA cycle collapse and cell death, which can be rescued by oxaloacetate or membrane-permeable α-ketoglutarate.
“In c-myc-transformed cells in particular, glutamine deprivation leads to the collapse of the TCA cycle and triggers cell death, which can be rescued by the addition of oxaloacetate or a membrane-permeable form of α-ketoglutarate (Wise et al., 2008; Yuneva et al., 2007).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Yuneva et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
MYC-associated DNA damage is both reported and denied
MajorThe Discussion says no increase in DNA damage was detected after ERTM-MYC activation, but the Results say ERTM-MYC activation induced phosphorylation of H2AX, which the paper uses as a DNA-damage reporter.
“However, we detected no increase in the concentration of ROS or DNA damage either after activation of ERTM-MYC or depleting glutathione.”
“Phosphorylation of H2AX, as detected by immunofluorescence, was induced by etoposide and by activation of ERTM-MYC, but not by glutamine depletion (Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1).”
CrmA result cites a nonexistent Figure 3 panel
MinorThe text cites Figure 3 D for the CrmA result, but the Figure 3 caption identifies the CrmA experiment as panel C and lists no panel D.
“whereas crmA, a viral inhibitor of the extrinsic pathway (Enari et al., 1995), had no effect (Fig. 3 D).”
“(C) IER-MYC transduced with CrmA or vector alone were treated as in A except anti-Fas (α-CD95) antibody was added as indicated.”
Figure 6 C refers to a schematic as its treatment protocol
MinorThe caption says the cells in panel C were treated as in panel A, but panel A is a biosynthesis diagram. The treatment conditions are described in panel B.
“(C) IER-MYC cells were treated as in A except the cells were collected at 24 h of incubation in the indicated media to determine the rate of apoptosis.”
“(A) Biosynthesis of glutathione. (B) IER-MYC–C9DN were incubated with OHT (MYCON) or ethanol (MYCOFF) for 24 h, and then transferred to the medium depleted of glutamine or supplemented with 100 μM BSO.”
Cites
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078 · see citing works
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1× · see citing works
“Glucose metabolism has drawn much of the attention (for review see Garber, 2006) from the time when Otto Warburg found that some cancer cells consume more glucose than normal cells and proposed that a failure to make ATP by oxidative phosphorylation is the cause of cancer (Warburg, 1956).”
BackgroundDNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · cited 4× · see citing works
“S2 visualizes localization of phosphorylated histone H2AX in cells deprived of glutamine or treated with etoposide.”
BackgroundInfluentialCillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D. A., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,153 · see citing works
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,416 · cited 1× · see citing works
“For example, citrate is used for the synthesis of fatty acids whose defi ciency might change permeability of mitochondrial membranes and affect their regulation by the Bcl-2 proteins (Green and Kroemer, 2004).”
BackgroundSuccinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1× · see citing works
“Some of the Krebs cycle intermediates, such as fumarate, succinate, and 2-oxoglutarate, can function as messenger and cofactor molecules directly regulating activity of enzymes and thereby contributing to regulation of gene transcription and/or tumorigenesis (Selak et al., 2005; Chen et al., 2006).”
BackgroundRas, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019 · cited 1× · see citing works
“The differences between cancer and normal cells in consumption and metabolism of basic nutrients have been considered a promising cancer therapy target for several decades (for review see Thompson et al., 2005; Shaw and Cantley, 2006).”
BackgroundGriffith, O. W., & Meister, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35980-5 · Cited by 1,683 · see citing works
Translational control in stress and apoptosis
Holčı́k, M., & Sonenberg, N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1618 · Cited by 1,366 · cited 1× · see citing works
“…review see Baggetto, 1992; Curi et al., 2005), abnormal expression of MYC accelerates cell proliferation and changes metabolism of mitochondria (Morrish et al., 2003; Li et al., 2005), and even a transient decrease in ATP concentration can cause apoptosis (Izyumov et al., 2004; Shaw et al., 2004).”
BackgroundmTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322 · cited 1× · see citing works
“The availability of nitrogen sources, and glutamine in particular, regulates the activity of mTOR, a kinase that controls protein synthesis, cell proliferation, and other processes that require nitrogen (for review see Sabatini, 2006).”
BackgroundEvidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240 · see citing works
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163 · cited 2× · see citing works
“This view was also supported by the observation that depletion of glucose induced apoptosis in rodent cells that were transduced with MYC, an oncogene that is abnormally expressed in many human cancers (Nesbit et al., 1999), but not in the parental cell line (Shim et al.”
BackgroundTranscriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,122 · cited 1× · see citing works
“Several hypotheses have been proposed to explain this sensitization (for review see (Adhikary and Eilers, 2005).”
BackgroundThe LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,067 · cited 2× · see citing works
“…review see Baggetto, 1992; Curi et al., 2005), abnormal expression of MYC accelerates cell proliferation and changes metabolism of mitochondria (Morrish et al., 2003; Li et al., 2005), and even a transient decrease in ATP concentration can cause apoptosis (Izyumov et al., 2004; Shaw et al., 2004).”
BackgroundQuantitative Metabolome Analysis Using Capillary Electrophoresis Mass Spectrometry
Soga, T., Ohashi, Y., Ueno, Y., Naraoka, H., Tomita, M., & Nishioka, T. (2003) · Journal of Proteome Research · doi:10.1021/pr034020m · Cited by 975 · cited 2× · see citing works
“To test this possibility we used capillary electrophoresis coupled to mass spectrometry (CE-MS), an approach that estimates concentration of multiple metabolites in one sample (Soga et al., 2003).”
MethodDeregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D. R., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 876 · cited 2× · see citing works
“Finally, MYC may affect multiple metabolic pathways (Osthus et al., 2000; O’Connell et al., 2003), including concentrations of some mitochondrial proteins (Morrish et al.”
Backgroundc-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876 · cited 3× · see citing works
“…glutathione defi ciency Abnormally high activity of MYC could produce suffi cient amounts of reactive oxygen species (ROS) to cause DNA damage, genomic instability, and apoptosis (Vafa et al., 2002), perhaps by affecting expression of mitochondrial proteins (Morrish et al., 2003; Li et al., 2005).”
BackgroundClinical Applications of PET in Oncology
ROHREN, E. M., Turkington, T. G., & Coleman, R. E. (2004) · Radiology · doi:10.1148/radiol.2312021185 · Cited by 862 · cited 1× · see citing works
“Many cancer cells indeed accumulate glucose derivatives faster than normal tissues, the ability that has been used successfully for cancer diagnosis and monitoring (for review see Rohren et al., 2004).”
BackgroundLittlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 780 · cited 2× · see citing works
“This system uses a fusion of MYC with a mutated hormonebinding domain of the estrogen receptor, ERTM-MYC (Eilers et al., 1989; Littlewood et al., 1995).”
BackgroundInvolvement of an ICE-like protease in Fas-mediated apoptosis
Enari, M., Hug, H., & Nagata, S. (1995) · Nature · doi:10.1038/375078a0 · Cited by 732 · cited 1× · see citing works
“3, A and B), whereas crmA, a viral inhibitor of the extrinsic pathway (Enari et al., 1995), had no effect (Fig.”
BackgroundCancer metabolism: facts, fantasy, and fiction
Zu, X. L., & Guppy, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.136 · Cited by 618 · cited 3× · see citing works
“However, the idea that restricting supply of glucose or imitating this restriction can kill cancer cells selectively by depleting ATP is not without its critics (for review see Zu and Guppy, 2004).”
BackgroundInfluentialMyc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis
Li, F., Wang, Y., Zeller, K. I., Potter, J. J., Wonsey, D. R., O’Donnell, K. A., Kim, J., Yustein, J. T., Lee, L. A., & Dang, C. V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6225-6234.2005 · Cited by 615 · cited 6× · see citing works
“Finally, MYC may affect multiple metabolic pathways (Osthus et al., 2000; O’Connell et al., 2003), including concentrations of some mitochondrial proteins (Morrish et al., 2003; Li et al., 2005), thus facilitating apoptosis.”
BackgroundInfluentialMolecular mechanisms of glutamine action
Curi, R., Lagranha, C. J., Doi, S. Q., Sellitti, D. F., Procopio, J., Pithon‐Curi, T. C., Corless, M., & Newsholme, P. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20339 · Cited by 497 · cited 3× · see citing works
“…used by the cells in a variety of ways, including oxidation by the Krebs cycle to produce ATP (for review see Baggetto, 1992), providing nitrogen required for nucleotide synthesis, and being a precursor of glutathione, the major nonenzymatic cellular anti-oxidant (for review see Curi et al., 2005).”
BackgroundThe Measurement of Pyridine Nucleotides by Enzymatic Cycling
Lowry, O. H., Passonneau, J. V., Schulz, D. W., & Rock, M. K. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61729-1 · Cited by 494 · see citing works
Bim is a suppressor of Myc-induced mouse B cell leukemia
Egle, A., Harris, A. W., Bouillet, P., & Cory, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401471101 · Cited by 482 · cited 1× · see citing works
“For example, increasing the ratio of Bcl-2 proteins may ease permeabilization of the mitochondria after various kinds of stress (Maclean et al., 2003; Egle et al., 2004).”
BackgroundChimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
Eilers, M., Picard, D., Yamamoto, K. R., & Bishop, J. M. (1989) · Nature · doi:10.1038/340066a0 · Cited by 458 · cited 5× · see citing works
“…William Tansey (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY). pBABE-hygroER-MYC and pBABE-puro MYC-ER plasmids were described previously (Eilers et al., 1989). cDNAs encoding caspase-9 Cys287 to Ser mutant (caspase 9 dominant negative, C9DN) (Fearnhead et al., 1998), crmA, Bcl-2, and…”
BackgroundMethodInfluentialMoreadith, R. W., & Lehninger, A. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82128-0 · Cited by 415 · see citing works
Structural Insights into Histone Demethylation by JMJD2 Family Members
Chen, Z., Zang, J., Whetstine, J. R., Hong, X., Davrazou, F., Kutateladze, T. G., Simpson, M., Mao, Q., Pan, C., Dai, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.04.024 · Cited by 396 · cited 1× · see citing works
“Some of the Krebs cycle intermediates, such as fumarate, succinate, and 2-oxoglutarate, can function as messenger and cofactor molecules directly regulating activity of enzymes and thereby contributing to regulation of gene transcription and/or tumorigenesis (Selak et al., 2005; Chen et al., 2006).”
BackgroundThe role of high rates of glycolysis and glutamine utilization in rapidly dividing cells
Newsholme, E. A., Crabtree, B., & Ardawi, M. S. (1985) · Bioscience Reports · doi:10.1007/bf01116556 · Cited by 364 · cited 2× · see citing works
“Moreover, only a few percent of the consumed glutamine is used for macromolecular biosynthesis, while the rest is metabolized into molecules, such as lactate, that are released by the cells (for review see Newsholme et al., 1985).”
BackgroundPerturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
Ramanathan, A., Wang, C., & Schreiber, S. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502267102 · Cited by 357 · cited 1× · see citing works
“The observed diversity was consistent with the fi nding that metabolism of human cells is changed by oncogenes in various ways (Ramanathan et al., 2005) and indicated that how nutrient depletion affects cancers and normal cells may be diffi - cult to conclude by extrapolating fi ndings obtained in…”
BackgroundA comparison of cell and tissue extraction techniques using high‐resolution 1H‐NMR spectroscopy
Belle, J. E. L., Harris, N. G., Williams, S. R., & Bhakoo, K. K. (2002) · NMR in Biomedicine · doi:10.1002/nbm.740 · Cited by 292 · cited 1× · see citing works
“Metabolites were extracted from adherent cells by a procedure adopted from Le Belle et al. (2002).”
MethodA unique glucose-dependent apoptotic pathway induced by c-Myc
Shim, H., Chun, Y. S., Lewis, B. C., & Dang, C. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1511 · Cited by 286 · cited 7× · see citing works
“…by acute activation of ectopically expressed MYC vary with cell type We found that depletion of glutamine but not glucose induces MYC-dependent apoptosis in human cells, whereas a previous report indicated that glucose depletion caused MYC-dependent apoptosis in a rat cell line (Shim et al., 1998).”
BackgroundResultInfluentialSecretion of pyruvate. An antioxidant defense of mammalian cells.
O’Donnell-Tormey, J., Nathan, C. F., Lanks, K. W., DeBoer, C. J., & de la Harpe, J. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.165.2.500 · Cited by 281 · see citing works
Energy Deregulation: Licensing Tumors to Grow
Garber, K. (2006) · Science · doi:10.1126/science.312.5777.1158 · Cited by 275 · cited 1× · see citing works
“Glucose metabolism has drawn much of the attention (for review see Garber, 2006) from the time when Otto Warburg found that some cancer cells consume more glucose than normal cells and proposed that a failure to make ATP by oxidative phosphorylation is the cause of cancer (Warburg, 1956).”
BackgroundDeviant energetic metabolism of glycolytic cancer cells
Baggetto, L. G. (1992) · Biochimie · doi:10.1016/0300-9084(92)90016-8 · Cited by 268 · cited 6× · see citing works
“Therefore, glutamine might support cell viability not by providing biosynthetic precursors, but by enabling the Krebs cycle to function as a catalyst of redox reactions (Kovacevic, 1972; Baggetto, 1992).”
BackgroundInfluentialCaspases Disrupt the Nuclear-Cytoplasmic Barrier
Faleiro, L. J., & Lazebnik, Y. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.5.951 · Cited by 248 · cited 1× · see citing works
“Retroviruses were produced and used to infect primary cells as described previously (Faleiro and Lazebnik, 2000).”
MethodSelf-citationMetabolism and action of amino acid analog anti-cancer agents
Ahluwalia, G. S., Grem, J. L., Hao, Z., & Cooney, D. A. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90094-i · Cited by 241 · cited 8× · see citing works
“by inducing nucleotide defi ciency (Ahluwalia et al., 1990).”
BackgroundInfluentialGlutamine: a major energy source for cultured mammalian cells.
Zielke, H. R., Zielke, C. L., & Pt, O. (1984) · PubMed · Cited by 240 · see citing works
Yang, N.-C., Ho, W., Chen, Y., et al. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5698 · Cited by 237 · cited 2× · see citing works
“Cells grown in 12-well plates were collected and washed with cold PBS. ATP was extracted by adding 1 ml of boiling water to the cell pellet as described previously (Yang et al., 2002).”
MethodA Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns
O’Connell, B. C., Cheung, A. F., Simkevich, C. P., Tam, W., Ren, X., Mateyak, M. K., & Sedivy, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210462200 · Cited by 227 · cited 3× · see citing works
“Finally, MYC may affect multiple metabolic pathways (Osthus et al., 2000; O’Connell et al., 2003), including concentrations of some mitochondrial proteins (Morrish et al.”
BackgroundPelengaris, S., & Khan, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00294-7 · Cited by 226 · see citing works
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou, W., Simpson, P. J., McFadden, J. M., Townsend, C. A., Medghalchi, S. M., Vadlamudi, A., Pinn, M. L., Ronnett, G. V., & Kuhajda, F. P. (2003) · PubMed · Cited by 216 · see citing works
c-Myc Phosphorylation Is Required for Cellular Response to Oxidative Stress
Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M. F., Zupi, G., & Biroccio, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.009 · Cited by 207 · cited 2× · see citing works
“MYC is also implicated in regulating concentration of glutathione (Benassi et al., 2006), the most abundant nonenzymatic antioxidant in the cell (Anderson et al.”
BackgroundMedina, M. Á. (2001) · Journal of Nutrition · doi:10.1093/jn/131.9.2539s · Cited by 182 · cited 1× · see citing works
“…A ugust 18, 2017 jcb.rupress.org D ow nloaded from http://doi.org/10.1083/jcb.200703099 Supplemental material can be found at: JCB • VOLUME 178 • NUMBER 1 • 2007 94 and some cancer cell lines require glutamine or its metabolites for survival (for review see Medina, 2001; Fuchs and Bode, 2006).”
BackgroundInfluential“Wages of Fear”: transient threefold decrease in intracellular ATP level imposes apoptosis
Izyumov, D. S., Avetisyan, A. V., Pletjushkina, O. Y., Sakharov, D. V., WIRTZ, K. W. A., Chernyak, B. V., & Skulachev, V. P. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.05.007 · Cited by 179 · cited 2× · see citing works
“…review see Baggetto, 1992; Curi et al., 2005), abnormal expression of MYC accelerates cell proliferation and changes metabolism of mitochondria (Morrish et al., 2003; Li et al., 2005), and even a transient decrease in ATP concentration can cause apoptosis (Izyumov et al., 2004; Shaw et al., 2004).”
BackgroundOncogene-dependent apoptosis is mediated by caspase-9
Fearnhead, H. O., Rodriguez, J., Govek, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13664 · Cited by 173 · cited 4× · see citing works
“97 the preceding steps of apoptosis (Fearnhead et al., 1998), thus avoiding artifacts associated with cell decomposition.”
BackgroundMethodInfluentialSelf-citationNath, K. A., Ngo, E. O., Hebbel, R. P., Croatt, A. J., Zhou, B., & Nutter, L. M. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c227 · Cited by 139 · cited 1× · see citing works
“Alternatively, pyruvate, oxaloacetate, and other α-ketoacids could function as antioxidants by binding hydrogen peroxide (O’DonnellTormey et al., 1987; Nath et al., 1995).”
Backgroundc-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-X L
Maclean, K. H., Keller, U. B., Galindo, C. R., Nilsson, J. A., & Cleveland, J. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7256-7270.2003 · Cited by 128 · cited 1× · see citing works
“For example, increasing the ratio of Bcl-2 proteins may ease permeabilization of the mitochondria after various kinds of stress (Maclean et al., 2003; Egle et al., 2004).”
Backgroundc-MYC apoptotic function is mediated by NRF-1 target genesPreprint
Morrish, F. M., Giedt, C. D., & Hockenbery, D. M. (2003) · Genes & Development · doi:10.1101/gad.1032503 · Cited by 123 · cited 6× · see citing works
“Finally, MYC may affect multiple metabolic pathways (Osthus et al., 2000; O’Connell et al., 2003), including concentrations of some mitochondrial proteins (Morrish et al., 2003; Li et al., 2005), thus facilitating apoptosis.”
BackgroundInfluentialLactate: A major product of glutamine metabolism by human diploid fibroblasts
Zielke, H. R., Sumbilla, C. M., Sevdalian, D. A., Hawkins, R. L., & Ozand, P. T. (1980) · Journal of Cellular Physiology · doi:10.1002/jcp.1041040316 · Cited by 123 · cited 11× · see citing works
“This cycle has two main functions: to supply NADH and FADH for oxidative phosphorylation by reducing FAD+ and NAD+ and Figure 8.”
BackgroundInfluentialThe continuous growth of vertebrate cells in the absence of sugar.
Wice, B. M., Reitzer, L., & Kennell, D. E. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43351-0 · Cited by 118 · cited 1× · see citing works
“Some cancer cells can even survive in vitro without glucose at all if supplied with glutamine and nucleosides (Reitzer et al., 1979; Wice et al., 1981; Linker et al., 1985).”
BackgroundBeginnings of a signal-transduction pathway for bioenergetic control of cell survival
Hammerman, P. S., Fox, C. J., & Thompson, C. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.008 · Cited by 115 · cited 1× · see citing works
“The more recent fi ndings that glucose metabolism is linked to signaling pathways of cell growth and survival, and apoptosis in particular (for review see Hammerman et al., 2004; Fulda and Debatin, 2007) only reinforced the view of glucose metabolism as the Achilles heel of cancer cells.”
BackgroundThe proportionality of glutaminase content to growth rate and morphology of rat neoplasms.
Knox, W. E., Horowitz, M. L., & Friedell, G. H. (1969) · PubMed · Cited by 112 · see citing works
Glutaminase activities and growth rates of rat hepatomas.
Linder-Horowitz, M., Knox, W. E., & Hp, M. (1969) · PubMed · Cited by 111 · see citing works
Stressing Out Over Survival: Glutamine as an Apoptotic Modulator
Fuchs, B. C., & Bode, B. P. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2005.07.013 · Cited by 111 · cited 2× · see citing works
“The second possibility seemed more likely because abnormal expression of MYC sensitizes cells to various agents that induce apoptosis (for review see Pelengaris and Khan, 2003) and because previous reports suggested that depletion of glutamine kills because of stress caused by defi ciency in proteins, ATP, glutathione…”
BackgroundMolecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells
Bode, B. P., Fuchs, B. C., Hurley, B. P., Conroy, J. L., Suetterlin, J. E., Tanabe, K. K., Rhoads, D. B., Abcouwer, S. F., & Souba, W. W. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00031.2002 · Cited by 105 · cited 2× · see citing works
“The rate of glutamine transport is higher in cancerous than in normal cells (Bode et al., 2002), the activity of glutaminase, the fi rst enzyme in glutamine metabolism, correlates with the growth rates of tumors (Knox et al.”
BackgroundCo-expression of glutaminase K and L isoenzymes in human tumour cells
Pérez‐Gómez, C., Campos-Sandoval, J. A., Alonso, F. J., SEGURA, J. A., Manzanares, E., RUIZ-SÁNCHEZ, P., GONZÁLEZ, M. E., Márquez, J., & Matés, J. M. (2005) · Biochemical Journal · doi:10.1042/bj20040996 · Cited by 100 · cited 2× · see citing works
“…et al., 2002), the activity of glutaminase, the fi rst enzyme in glutamine metabolism, correlates with the growth rates of tumors (Knox et al., 1969; Linder-Horowitz et al., 1969; Perez-Gomez et al., 2005), Defi ciency in glutamine but not glucose induces MYC-dependent apoptosis in human cells”
BackgroundJonas, E. A., Hickman, J. A., Chachar, M., Polster, B. M., Brandt, T. A., Fannjiang, Y., Ivanovska, I., Basáñez, G., Kinnally, K. W., Zimmerberg, J. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401372101 · Cited by 99 · cited 2× · see citing works
“Although we found that a defi ciency in oxidative phosphorylation does not cause apoptosis in our system, a change in the mitochondrial NADH/NAD+ and FADH/FAD+ ratios, which we did not measure, could affect other processes, including regulation of gene transcription (for review see Ladurner, 2006) and mitochondrial pe…”
BackgroundRheostat Control of Gene Expression by Metabolites
Ladurner, A. G. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.002 · Cited by 95 · cited 2× · see citing works
“Because the NADH/NAD ratio determines rates of many processes, from glycolysis to histone modifi cations (for review see Ladurner, 2006), affecting this ratio could induce apoptosis.”
BackgroundHIF-1-Regulated Glucose Metabolism: A Key to Apoptosis Resistance?
Fulda, S., & Debatin, K. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4084 · Cited by 93 · cited 1× · see citing works
“The more recent fi ndings that glucose metabolism is linked to signaling pathways of cell growth and survival, and apoptosis in particular (for review see Hammerman et al., 2004; Fulda and Debatin, 2007) only reinforced the view of glucose metabolism as the Achilles heel of cancer cells.”
BackgroundMaRX: An Approach to Genetics in Mammalian Cells
Hannon, G. J., Sun, P., Carnero, A., Xie, L. Y., Maestro, R., Conklin, D. S., & Beach, D. (1999) · Science · doi:10.1126/science.283.5405.1129 · Cited by 93 · cited 2× · see citing works
“, 1998), crmA, Bcl-2, and human c-MYC were cloned into a MarX-IV-puro retroviral gene transfer vector (Hannon et al., 1999).”
Panosyan, E. H., Grigoryan, R. S., Avramis, I. A., Seibel, N. L., Gaynon, P. S., Siegel, S. E., Fingert, H. J., & Avramis, V. I. (2004) · PubMed · Cited by 78 · see citing works
The Tumor Suppressor cybL, a Component of the Respiratory Chain, Mediates Apoptosis Induction
Albayrak, T., Scherhammer, V., Schoenfeld, N., Braziulis, E., Mund, T., Bauer, M. K. A., Scheffler, I. E., & Grimm, S. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0631 · Cited by 75 · cited 2× · see citing works
“html), a defi ciency in the Krebs cycle or its intermediates could have various consequences, including apoptosis, even if the normal ATP concentration is maintained by glycolysis (Albayrak et al., 2003; Zhou et al., 2003).”
BackgroundProfile of energy metabolism in a murine hybridoma: Glucose and glutamine utilization
Petch, D., & Butler, M. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610110 · Cited by 63 · cited 1× · see citing works
“…in our system is either the main source of Krebs cycle intermediates, as in some proliferating normal and cancer cells (Reitzer et al., 1979; Moreadith and Lehninger, 1984; Zielke et al., 1984; Kovacevic et al., 1991; Baggetto, 1992; Petch and Butler, 1994), or regulates the Krebs cycle activity.”
BackgroundAnderson, C. P., Tsai, J. M., Chan, W., Park, C. K., Tian, L., Lui, R., Forman, H. J., & Reynolds, C. P. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00203-7 · Cited by 41 · cited 4× · see citing works
“As expected, depletion of glutamine decreased glutathione concentration in IER-MYC–C9DN cells, as did l-buthionine sulfoximine (BSO), an inhibitor of l-glutamylcysteine synthase (Griffi th and Meister, 1979; Anderson et al., 1997) (Fig.”
BackgroundInfluentialHow Do Cancer Cells Acquire the Fuel Needed to Support Cell Growth?Preprint
Thompson, C. B., Bauer, D. E., Lum, J. J., et al. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.011 · Cited by 34 · see citing works
Control and function of the transamination pathways of glutamine oxidation in tumour cells
Kovačević, Z., Brkljač, O., & Bajin, K. (1991) · Biochemical Journal · doi:10.1042/bj2730271 · Cited by 24 · cited 2× · see citing works
“Indeed, our observations indicated that glutamine in our system is either the main source of Krebs cycle intermediates, as in some proliferating normal and cancer cells (Reitzer et al., 1979; Moreadith and Lehninger, 1984; Zielke et al., 1984; Kovacevic et al., 1991; Baggetto, 1992; Petch and Butler, 1994), or regulat…”
BackgroundReversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine
Stet, E. H., ABREU, R. A. D., Bökkerink, J. P. M., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00387-2 · Cited by 23 · cited 2× · see citing works
“As expected, p53 concentration was induced by DON, 6-methylmercaptopurine riboside (MMPR), an inhibitor of nucleotide synthesis (Stet et al., 1995), etoposide, which causes double-stranded DNA breaks, or by activation of ectopically expressed ERTMMYC (Fig.”
BackgroundKovačević, Z. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb01706.x · Cited by 23 · cited 2× · see citing works
“Apoptosis caused by glutamine depletion is prevented by substrates of the Krebs cycle Because glutamine can be converted via glutamate into 2-oxoglutarate, a Krebs cycle intermediate (Kovacevic, 1972; Baggetto, 1992), depletion of this amino acid could cause a defi ciency of this cycle.”
BackgroundGuérin, P. J., Furtak, T., Eng, K., & Gauthier, E. R. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.11.004 · Cited by 22 · cited 1× · see citing works
“4 B), and a report that BSO failed to recapitulate apoptosis caused by glutamine deprivation in a hybridoma (Guerin et al., 2006).”
BackgroundLinker, W., Löffler, M., & Schneider, F. (1985) · PubMed · Cited by 18 · see citing works
[21] Flow cytometric determination of cellular thiols
Sen, C. K., Roy, S., & Packer, L. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)99024-9 · Cited by 11 · cited 2× · see citing works
“The amount of reduced glutathione in cells was measured by fl ow cytometry as described previously (Sen et al., 1999).”
Method
Flagged first, then by citations
Research works printed but not linked: 6
- 1969, Cancer Res., 29, 669
- 1969, Cancer Res., 29, 1195
- 1985, Eur. J. Cell Biol., 36, 176
- 2004, Anticancer Res., 24, 1121
- 2003, Cancer Res., 63, 7330
- 1984, Fed. Proc., 43, 121
Cited by
Sorted by citations
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · see citing works
“Impressively, glutamine deprivation from fibroblast cultures essentially eliminates pools of the TCA cycle intermediates fumarate and malate (Yuneva et al., 2007).”
BackgroundInfluentialDang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390 · see citing works
“Likewise, glutamine withdrawal triggers apoptosis of Myc-overexpressing cells (Yuneva et al., 2007).”
BackgroundOtto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427 · see citing works
“Thus, overexpression of MYC in cancer cells renders them sensitive to glutamine withdrawa”
BackgroundMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · see citing works
“While the role of glutamine as a nitrogen donor is important for the proliferation of these cells, their viability depends on glutamine as a carbon source for mitochondrial metabolism (DeBerardinis et al., 2007; Fan et al., 2010; Gao et al., 2009; Wise et al., 2008; Yuneva et al., 2007).”
BackgroundAerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057 · see citing works
“Glutamine depletion induces MYC-dependent apoptosis of normal human fibroblasts, but apoptosis can be rescued by addition of pyruvate or oxaloacetate (Yuneva et al 2007).”
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works
“Most cultured cells require glutamine, and providing cells with αKG or other TCA cycle intermediates can rescue proliferation in low glutamine conditions (Yuneva et al., 2007).”
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119 · see citing works
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works
“(23) have reported that some, but not all, Myc transformants were dependent on glutamine.”
BackgroundGlutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · see citing works
“Oncogenic levels of Myc have recently been linked to increased glutaminolysis through a coordinated transcriptional program [26,40,41].”
BackgroundReprogramming of fatty acid metabolism in cancer
Koundouros, N., & Poulogiannis, G. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0650-z · Cited by 1,621 · see citing works
“Moreover, amplification of the MYC oncogene drives increased glutamine metabolism and anaplerosis by transcriptionally activating mitochondrial glutaminase (GLS1) and the SLC1A5 glutamine transporter.(60,61) Hyperactivation of the phosphoinositide 3-kinase and AKT (PI3K–AKT) pathway has also been implicated in the rew…”
BackgroundTargeting cancer metabolism: a therapeutic window opens
Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,409 · see citing works
“, and MYC -dependent cells have a particular reliance on glutamine metabolis”
BackgroundQ's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365 · see citing works
“Enhanced c-Myc activity was sufficient to drive glutamine metabolism and to impair cell survival in low-glutamine conditions (Yuneva et al., 2007; Wise et al., 2008). c-Myc regulates glutamine metabolism in part by stimulating the expression of surface transporters (Wise et al., 2008).”
BackgroundZong, W., Rabinowitz, J. D., & White, E. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.011 · Cited by 1,287 · see citing works
“This replenishment of the TCA cycle 4C units is termed anaplerosis and can occur through carboxylation of pyruvate or catabolism of glutamine and other amino acids (Comerford et al., 2014; DeBerardinis et al., 2007; Fan et al., 2009; Mashimo et al., 2014; Yuneva et al., 2007).”
BackgroundGlutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262 · see citing works
“This requirement for glutamine is particularly true in cancer cells, many of which display oncogene-dependent addictions to glutamine in culture (8).”
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189 · see citing works
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095 · see citing works
“Although MYC-overexpressing cells appear to become addicted to glutamine, the heightened addiction to glutamine under hypoxia had not been previously established (Yuneva et al., 2007).”
Tumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085 · see citing works
Metabolic requirements for the maintenance of self-renewing stem cells
Ito, K., & Suda, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3772 · Cited by 1,014 · see citing works
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018 · see citing works
“More recently, glutamine deprivation from fibroblasts was shown to reduce cellular pools of TCA cycle intermediates [61].”
BackgroundEnergy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Zheng, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 953 · see citing works
“However, these cells in medium without glutamine induced Myc-dependent apoptosis (43), suggesting that interfering with glutaminolysis may obtain better therapeutic effects than interfering with glucose in certain cancers.”
BackgroundTargeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works
“Providing cells with αKG, oxaloacetate, or pyruvate is sufficient to rescue cancer cell proliferation in conditions of glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates, a process termed anaplerosis (Altman et al., 2016; Weinberg et al., 2010; Yunev…”
BackgroundMYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 934 · see citing works
“It is notable that Myc-overexpressing human cell lines were found to be dependent on glutamine, such that its withdrawal triggered apoptosis (39).”
BackgroundCancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 945 · see citing works
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859 · see citing works
“Acute glutamine deprivation in cells causes apoptosis and cell shrinkage triggered by the CD95-mediated caspase cascade (105, 106).”
BackgroundMiller, D. M., Thomas, S. D., Islam, A., Muench, D. E., & Sedoris, K. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0977 · Cited by 844 · see citing works
“This leads, in turn, to upregulation of glutamine catabolism (82), resulting in increased glutamate which is further metabolized through the TCA cycle or serves as a substrate”
Targeting oncogenic Myc as a strategy for cancer treatment
Chen, H., Liu, H., & Qing, G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0008-7 · Cited by 806 · see citing works
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687 · see citing works
“Cancer cells often consume glutamine, and those dependent on Myc signaling are highly sensitive to glutamine withdrawal (Yuneva et al., 2007).”
BackgroundCancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · see citing works
“In addition, a cell-permeable form of a -KG (dimethyl-a -KG) can completely suppress glutamine-depletion-induced apoptosis in MYC-trans-formed cells (Yuneva et al , 2007; Wise et al , 2008).”
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639 · see citing works
“(IMR90-ERMYC and HA1E-MYCER) that can be activated by 4-hydroxytamoxifen (OHT) (Yuneva et al., 2007), as well as HA1E cells that constitutively overexpress wild-type MYC (HA1E-MYC).”
BackgroundMethodInfluentialSelf-citationMechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 631 · see citing works
“Cancer cells deprived of glutamine rapidly die off [26], and increased glutamine metabolism in cancer is often referred to as “glutamine addiction”.”
BackgroundMYC, Metabolism, Cell Growth, and TumorigenesisPreprint
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 600 · see citing works
“In this regard, deregulated MYC expression predisposes cells to growth factor or nutrient deprivation-induced cell death, while deprived normal cells withdraw into the cell-cycle G1 phase (Askew et al. 1991; Evan et al. 1992; Shim et al. 1998; Yuneva et al. 2007).”
BackgroundRegulation of the pentose phosphate pathway in cancer
Jiang, P., Du, W., & Wu, M. (2014) · Protein & Cell · doi:10.1007/s13238-014-0082-8 · Cited by 568 · see citing works
“Interestingly, Myc-driven human cancer cells strongly depend on glutamine and are dramatically sensitive to glutamine starvation (Yuneva et al., 2007).”
BackgroundTimmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · see citing works
“Thus GLS is a commonly proposed biomarker of glutamine-dependence and therapeutic target (Lobo et al., 2000; Lora et al., 2004; Wang et al., 2010, Yuneva et al., 2007; van den Heuvel et al., 2012), and GLUL a marker of glutamine independence (Collins et al., 1998; Kung et al., 2011).”
InfluentialSelf-citationTardito, S., Oudin, A., Ahmed, S. U., Fack, F., Keunen, O., Zheng, L., Miletic, H., Sakariassen, P. Ø., Weinstock, A., Wagner, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3272 · Cited by 557 · see citing works
“While it has been proposed that c-Myc determines Gln addiction by increasing GLS expression 3,23,24 , MYC -induced lung tumours were shown to increase GS expression 2 .”
Feron, O. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.025 · Cited by 559 · see citing works
“Some Myc-transformed cells were identified by Yuneva and colleagues to be strictly dependent on glutaminolysis: deprivation of glutamine actually led to cell death [32].”
BackgroundAmino acid metabolism in health and disease
Ling, Z., Jiang, Y.-F., Ru, J.-N., Lu, J.-H., Ding, B., & Wu, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01569-3 · Cited by 574 · see citing works
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529 · see citing works
“…cells with high levels of c-Myc have high rates of glutamine catabolism and require glutamine for survival and growth in culture (Wise et al., 2008; Yuneva et al., 2007). c-Myc regulates levels of glutaminase (GLS), one of the enzymes that converts glutamine to glutamate in cells that use…”
BackgroundMitochondrial Dysfunction in Cancer
Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 502 · see citing works
“Withdrawal of glutamine causes Myc-driven tumor cells to apoptose (398, 399) and this is now being exploited for therapeutic purposes, as recently reported for N-Myc-driven neuroblastomas (400).”
BackgroundPhan, L. M., Yeung, S. J., & Lee, M. H. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.001 · Cited by 500 · see citing works
Oncogenic K‐Ras decouples glucose and glutamine metabolism to support cancer cell growth
Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., & Chiaradonna, F. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.56 · Cited by 492 · see citing works
“Although previous studies have shown an increase of Gln uptake in other kinds of cancer cell lines (Yuneva et al, 2007; Wise et al, 2008; Gao et al, 2009), we did not detect any significant changes in Gln uptake and Glu secretion between the two cell lines.”
Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497 · see citing works
Self-citationFor better or for worse: the role of Pim oncogenes in tumorigenesis
Nawijn, M. C., Alendar, A., & Berns, A. J. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2986 · Cited by 484 · see citing works
“, and MYC-driven transformation is characterized by glutamine addictio”
BackgroundPyruvate carboxylase is required for glutamine-independent growth of tumor cells
Cheng, T., Sudderth, J., Yang, C., Mullen, A. R., Jin, E. S., Matés, J. M., & DeBerardinis, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016627108 · Cited by 475 · see citing works
“Depriving such cells of glutamine leads to depletion of TCA cycle intermediates and growth failure (9, 10).”
BackgroundResultGlutaminolysis as a target for cancer therapy
Jin, L., Alesi, G. N., & Kang, S. (2016) · Oncogene · doi:10.1038/onc.2015.447 · Cited by 459 · see citing works
Pike, L. S., Smift, A., Croteau, N. J., Ferrick, D. A., & Wu, M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 473 · see citing works
“[24] reported that glutamine depletion-induced cell death in Myc-expressing human cells does not involve an increase in ROS levels.”
BackgroundMatés, J. M., Segura, J. A., Alonso, F. J., & Márquez, J. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0304-z · Cited by 460 · see citing works
“…even apparently simple problems, such as how a deWciency in glutamine induces apoptosis, is likely to require developing new approaches that can routinely measure, analyze, and model the complex metabolic and signal transduction networks performed by this particular amino acid (Yuneva et al. 2007).”
BackgroundAsparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Zhang, J., Fan, J., Venneti, S., Cross, J. R., Takagi, T., Bhinder, B., Djaballah, H., Kanai, M., Cheng, E. H., Judkins, A. R., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.018 · Cited by 439 · see citing works
“Many cancer cell lines exhibit dependence on glutamine to maintain cell survival and cell growth (Wise et al., 2008; Yuneva et al., 2007), and glutamine is the most commonly depleted amino acid in primary solid tumors (Roberts et al., 1956).”
BackgroundYang, C., Sudderth, J., Dang, T. T., Bachoo, R. G., McDonald, J. G., & DeBerardinis, R. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2266 · Cited by 425 · see citing works
“Rather, c-Myc stimulates glutamine metabolism by increasing the expression of amino acid transporters and GLS, resulting in increased glutamine catabolism and increased sensitivity to glutamine withdrawal (8, 9, 12).”
Perciavalle, R. M., Stewart, D. P., Koss, B. S., Lynch, J., Milasta, S., Bathina, M., Temirov, J. P., Harwig, M. C., Pelletier, S. W., Schuetz, J. D., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2488 · Cited by 407 · see citing works
Cancer metabolism: current perspectives and future directions
Muñoz-Pinedo, C., El Mjiyad, N., & Ricci, J.-E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.123 · Cited by 385 · see citing works
“but some reports indicate that cell death occurs via mitochondrial apoptosis, possibly mediated by the Noxa/ Mcl-1 axis.(84,85)”
BackgroundQuiescent Fibroblasts Exhibit High Metabolic Activity
Lemons, J. M. S., Feng, X., Bennett, B. D., Legesse-Miller, A., Johnson, E. L., Raitman, I., Pollina, E. A., RABITZ, H. A., Rabinowitz, J. D., & Coller, H. A. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000514 · Cited by 377 · see citing works
“in proliferating fibroblasts [36–39].”
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.021 · Cited by 375 · see citing works
“Consequently, Gln depletion kills transformed cells in a Myc-dependent manner (Le et al., 2012; Wise et al., 2008; Yuneva et al., 2007).”
Guo, J. Y., Teng, X., Laddha, S. V., Ma, S., Nostrand, S. C. V., Yang, Y., Khor, S., Chan, C. S., Rabinowitz, J. D., & White, E. (2016) · Genes & Development · doi:10.1101/gad.283416.116 · Cited by 373 · see citing works
“The replenishment of TCA cycle metabolites can be achieved by the carboxylation of pyruvate or catabolism of glutamine or other amino acids (DeBerardinis et al. 2007; Yuneva et al. 2007; Fan et al. 2009; Comerford et al. 2014; Mashimo et al. 2014).”
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works
Nutrient acquisition strategies of mammalian cells
Palm, W., & Thompson, C. B. (2017) · Nature · doi:10.1038/nature22379 · Cited by 388 · see citing works
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Dang, C. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3556 · Cited by 379 · see citing works
“These observations, along with early observations that glutamine deprivation of Myc-transformed human cells triggered apoptosis (20), indicate that Myc stimulation of glutamine catabolism is part and parcel of its central role in integrating cell proliferation with metabolism.”
Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Daye, D., & Wellen, K. E. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.002 · Cited by 375 · see citing works
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Chen, H., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 351 · see citing works
Metabolic requirements for neutrophil extracellular traps formation
Rodríguez‐Espinosa, O., Rojas-Espinosa, O., Moreno‐Altamirano, M. M. B., López‐Villegas, E. O., & Sánchez‐García, F. J. (2014) · Immunology · doi:10.1111/imm.12437 · Cited by 360 · see citing works
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Tong, X., Zhao, F., & Thompson, C. B. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.002 · Cited by 351 · see citing works
“It is also increasingly appreciated that transformed cells consume large amounts of glutamine which can also be used to support anabolic synthesis [6 ,7].”
MYC and metabolism on the path to cancer
Hsieh, A. L., Walton, Z. E., Altman, B. J., Stine, Z. E., & Dang, C. V. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.003 · Cited by 337 · see citing works
Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy
Eng, C. H., Yu, K., Lucas, J., White, E., & Abraham, R. T. (2010) · Science Signaling · doi:10.1126/scisignal.2000911 · Cited by 334 · see citing works
“In addition, Myctransformed cells undergo rapid apoptosis upon withdrawal of Gln from the culture medium (50).”
BackgroundAs Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid
Pavlova, N. N., Hui, S., Ghergurovich, J. M., Fan, J., Intlekofer, A. M., White, R. M., Rabinowitz, J. D., Thompson, C. B., & Zhang, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.006 · Cited by 341 · see citing works
“Thus, a cell permeable a-KG was shown to be sufficient to rescue glutamine depletion-induced apoptosis in MYC-transformed cells (Wise et al., 2008; Yuneva et al., 2007).”
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 305 · see citing works
“Glutamine caron entry into the TCA cycle supports both ATP generation and iosynthesis, and a wide variety of cancer cell types are sensiive to glutamine withdrawal [28,29].”
Targeting Glutamine Metabolism for Cancer Treatment
Choi, Y., & Park, K. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.178 · Cited by 321 · see citing works
“Similar to KRAS, MYC-overexpressing cancer cells are often addicted to glutamine, such that glutamine deprivation results in MYC-dependent apoptosis (Yuneva et al., 2007).”
BackgroundShin, C.-S., Mishra, P., Watrous, J. D., Carelli, V., D’Aurelio, M., Jain, M., & Chan, D. C. (2017) · Nature Communications · doi:10.1038/ncomms15074 · Cited by 305 · see citing works
Therapeutic targets in cancer cell metabolism and autophagy
Cheong, H., Lü, C., Lindsten, T., & Thompson, C. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2285 · Cited by 316 · see citing works
Muir, A., Danai, L. V., Gui, D. Y., Waingarten, C. Y., Lewis, C. A., & Vander Heiden, M. G. (2017) · eLife · doi:10.7554/elife.27713 · Cited by 311 · see citing works
“Instead, glutamine metabolism is important for TCA cycle anaplerosis in multiple contexts (Altman et al., 2016; DeBerardinis et al., 2007; Yuneva et al., 2007).”
BackgroundStrategies to Inhibit Myc and Their Clinical Applicability
Whitfield, J. R., Beaulieu, M.-È., & Soucek, L. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00010 · Cited by 295 · see citing works
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
HU, J. L., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 292 · see citing works
“…aligns with multiple lines of evidence suggesting that mitochondrial competence is indeed important for cancer cell viability (Jose et al., 2011; Koppenol et al., 2011) and efficient oncogene-mediated transformation (Gao et al., 2009; Weinberg et al., 2010; Wise et al., 2008; Yuneva et al., 2007).”
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancerPreprint
Venkateswaran, N., Lafita‐Navarro, M. C., Hao, Y.-H., Kilgore, J. A., Perez‐Castro, L., Braverman, J., Borenstein‐Auerbach, N., Kim, M. G., Lesner, N. P., Mishra, P., et al. (2019) · Genes & Development · doi:10.1101/gad.327056.119 · Cited by 254 · see citing works
Kung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277 · see citing works
“. Such glutamine dependence or addiction is reflected in the growth restriction and cell death in glutamine limiting conditions. The glutamine addiction is also critical for c-myc-mediated oncogenesis”
BackgroundDeregulated MYC expression induces dependence upon AMPK-related kinase 5
Liu, L., Ulbrich, J., Müller, J., Wüstefeld, T., Aeberhard, L., Kress, T. R., Muthalagu, N., Rycak, L., Rudalska, R., Moll, R., et al. (2012) · Nature · doi:10.1038/nature10927 · Cited by 276 · see citing works
Signaling in Control of Cell Growth and MetabolismPreprint
Ward, P. S., & Thompson, C. B. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006783 · Cited by 270 · see citing works
“glutamine (Yuneva et al. 2007; Wise et al. 2008; Gao et al. 2009).”
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
Huang, X., Gan, G., Wang, X., Xu, T., & Xie, W. (2019) · Autophagy · doi:10.1080/15548627.2019.1580105 · Cited by 228 · see citing works
Emerging roles of Myc in stem cell biology and novel tumor therapies
Yoshida, G. J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0835-y · Cited by 244 · see citing works
Mitochondrial dysfunction in neurodegenerative diseases and cancer
de Moura, M. B., Santana‐Santos, L., & Houten, B. V. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20575 · Cited by 243 · see citing works
“Laz- ebnik and coworkers observed that glutamine, but not glucose depletion, promoted apoptosis in Myc-dependent manner [Yuneva et al., 2007].”
BackgroundChoo, A. Y., Kim, S. G., Heiden, M. G. V., Mahoney, S. J., Vu, H., Yoon, S.-O., Cantley, L. C., & Blenis, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.007 · Cited by 248 · see citing works
“…EGCG, an antioxidant in green tea extracts that inhibits GDH, effectively induced death in glucose-deprived cells that were protected by rapamycin but not in cells grown in the presence of sufficient glucose (2.0 mM versus 5.0 mM glucose) (Figures S6A–S6C) (Li et al., 2006; Yuneva et al., 2007).”
BackgroundInfluentialWe're Not “DON” Yet: Optimal Dosing and Prodrug Delivery of6-Diazo-5-oxo-L-norleucine
Lemberg, K. M., Vornov, J. J., Rais, R., & Slusher, B. S. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1148 · Cited by 238 · see citing works
“It was subsequently shown that when deprived of glutamine tumor cells undergo apoptosis (8).”
BackgroundMa, Z., Vocadlo, D. J., & Vosseller, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470047 · Cited by 255 · see citing works
“Cancer cells also consume glutamine at high rates and require high glutamine concentrations to survive (glutamine addiction) (4, 5).”
BackgroundHu, S., Balakrishnan, A., Bok, R. A., Anderton, B., Larson, P. E. Z., Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., & Goga, A. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.012 · Cited by 245 · see citing works
“Several prior studies have identified increased glutamine uptake and catabolism as an important energy source in cells that over-express MYC (Dang, 2010; Wise et al., 2008; Yuneva et al., 2007), but the in vivo importance of this pathway is less clear.”
Glutamine metabolism is essential for human cytomegalovirus infection
Chambers, J. W., Maguire, T. G., & Alwine, J. C. (2010) · Journal of Virology · doi:10.1128/jvi.02123-09 · Cited by 238 · see citing works
“Tumor cells have been shown to utilize a similar mechanism, and they become addicted to glutamine such that glutamine withdrawal causes cell death (19, 20).”
BackgroundInfluentialHeterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta‐Grigoriou, F. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 237 · see citing works
Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells?
Dang, C. V. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13302 · Cited by 245 · see citing works
Ma, G., Zhang, Z., Li, P., Zhang, Z., Zeng, M., Liang, Z., Li, D., Wang, L., Chen, Y., Liang, Y., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00909-0 · Cited by 235 · see citing works
Sheen, J.-H., Zoncu, R., Kim, D., & Sabatini, D. M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.012 · Cited by 241 · see citing works
“For example, human fibroblasts with activated c-MYC depend on glutamine (Yuneva et al., 2007), lymphoblastic leukemia cells require tryptophan, herapies are needed.”
BackgroundMYC and tumor metabolism: chicken and egg
Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240 · see citing works
“For example, MYC-driven tumor cells are dependent on a constant supply of glutamine and glutamine deprivation or inhibition of glutaminase can selectively kill cells with enhanced levels of MYC (Yuneva et al, 2007; Wise et al, 2008; Qing et al, 2012; Nieminen et al, 2013; Wiese et al, 2015).”
BackgroundRomero‐Garcia, S., López-González, J. S., ́ez-Viveros, J. L. B., Aguilar‐Cázares, D., & Prado-Garcı́a, H. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.11.18140 · Cited by 240 · see citing works
“In MYC-transformed cells, glutamine depletion induces apoptosis as a result of the decrease in Krebs cycle intermediaries.(72) c-Myc increases glutamine influx through transcriptional repression by miR-23a/b microRNAs, resulting in an increase in mitochondrial glutaminase expression, glutamine metabolism and the gluta…”
BackgroundDelving deeper: MCL-1's contributions to normal and cancer biology
Perciavalle, R. M., & Opferman, J. T. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.011 · Cited by 233 · see citing works
Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night
Mathew, R., & White, E. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.008 · Cited by 235 · see citing works
Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting
Alkan, H. F., Walter, K. E., Luengo, A., Madreiter‐Sokolowski, C. T., Stryeck, S., Lau, A. N., Zoughbi, W. A., Lewis, C. A., Thomas, C. J., Höefler, G., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.021 · Cited by 205 · see citing works
“Cell Metabolism vulnerable to glutamine withdrawal or glutaminase inhibition by drugs such as CB-839 (Gross et al., 2014; Yuneva et al., 2007).”
Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231 · see citing works
“…glutamine metabolism, hence targeting glutaminolysis in particular genetic subtypes of cancer has emerged as an attractive therapeutic option (Yuneva et al., 2007; Gao et al., 2009; Hu et al., 2010; Gaglio et al., 2011; Wise et al., 2011; Yuneva et al., 2012; Son et al., 2013; Qie et al.,…”
BackgroundKalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., López, M., Joseph, J., Zielonka, J., & Dwinell, M. B. (2017) · Redox Biology · doi:10.1016/j.redox.2017.09.020 · Cited by 236 · see citing works
“Indeed, Myc-expressing tumor cells undergo apoptosis in the absence of glutamine [86].”
BackgroundIs Cancer a Metabolic Disease?
Coller, H. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.035 · Cited by 230 · see citing works
“Some tumors organize the TCA cycles so that they are addicted to glucose for anaplerosis and survival,(99) whereas other tumors are glutamine dependent.(60,99) Tumors characterized by a strict reliance on either glucose or glutamine may be targetable through this metabolic vulnerability.”
BackgroundWaves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
Smolková, K., Plecitá‐Hlavatá, L., Bellancé, N., Bénard, G., Rossignol, R., & Ježek, P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.003 · Cited by 224 · see citing works
Cancer Metabolism and Elevated O-GlcNAc in Oncogenic Signaling
Ma, Z., & Vosseller, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.577718 · Cited by 212 · see citing works
“Cancer cells are also addicted to glutamine (26).”
BackgroundStable isotope-resolved metabolomics and applications for drug development
Fan, T. W. ‐., Lorkiewicz, P. K., Sellers, K., Moseley, H., Higashi, R. M., & Lane, A. N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.007 · Cited by 209 · see citing works
- Authors
- Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y.
- Affiliations
- University of California, San Francisco (US)
- ETH Zurich (CH)
- University of Regensburg (DE)
- Cold Spring Harbor Laboratory (US)
- Corresponding author
- Lazebnik, Yuri
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2007-07-02
- Volume
- 178
- Issue
- 1
- Pages
- 93-105
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2064426
- OpenAlex
- W2112861594
- Cited by
- 690
- References
- 72
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 26 · 2023: 46 · 2022: 36 · 2021: 36 · 2020: 32 · 2019: 40 · 2018: 39 · 2017: 56 · 2016: 49 · 2015: 47 · 2014: 50 · 2013: 46 · 2012: 42
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- National Cancer Institute (CA-13106-31, P01CA013106)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- glutamine deprivation, glucose deprivation, c-Myc, apoptosis, Krebs cycle intermediates, nutrient deprivation, cancer therapy, glutamine metabolism, cell viability, glucose metabolism
- MeSH terms
- Proto-Oncogene Mas, Cell Line, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Glucose, Glutamine, Humans, Lung, Male, Retroviridae, Skin, Transduction, Genetic, Proto-Oncogene Proteins c-myc, Apoptosis, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review